Cite
HARVARD Citation
Yoshida, T. et al. (2016). Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer. Lung cancer. pp. 43-47. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yoshida, T. et al. (2016). Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer. Lung cancer. pp. 43-47. [Online].